Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)

Market Cap	10.68B -2.9%
Revenue (ttm)	1.90B +20.5%
Net Income	498.69M +18.3%
EPS	1.61 +20.4%
Shares Out	316.05M
PE Ratio	20.96
Forward PE	15.86
Dividend	0.64 (1.90%)
Ex-Dividend Date	n/a

Volume	2,370,446
Average Volume	3,142,932
Open	33.97
Previous Close	34.05
Day's Range	33.78 - 34.35
52-Week Range	29.86 - 50.86
Beta	0.38
RSI	26.87
Earnings Date	Apr 30, 2026

About SHA:688076

Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company, engages in the research and development, production, and sale of peptides, oligonucleotides, and small molecule drugs in China. The company offers Peptide CDMO Services,GMP oligo, full-time equivalent, discovery, generic APIs, and formulation services. It is also involved in professional technical services. The company was founded in 2009 and is headquartered in Hangzhou, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2009
• Employees: 2,247
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688076

Financial Performance

In 2024, SHA:688076's revenue was 1.62 billion, an increase of 57.21% compared to the previous year's 1.03 billion. Earnings were 404.39 million, an increase of 148.19%.